Related Experiment Video
Updated: Jun 12, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Review: Nutriceuticals as antithrombotic agents.
Subrata Chakrabarti1, Jane E Freedman
1Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA. subrata@bu.edu
Cardiovascular Therapeutics
|June 18, 2010
Summary
Dietary antioxidants influence platelet-mediated thrombosis, but supplementation has risks. Nutrigenomics and nutraceuticals offer a promising, personalized approach to managing thrombosis and cardiovascular inflammation.
Area of Science:
- Cardiovascular Science
- Nutritional Science
- Pharmacology
Background:
- Thrombus formation is influenced by platelet redox state, reactive oxygen/nitrogen species, and antioxidants.
- Shear stress in stenotic arteries and superoxide/nitric oxide metabolism impact platelet activation and thrombosis.
- Traditional antioxidant supplementation shows limited cardiovascular benefit and carries risks like bleeding.
Purpose of the Study:
- To review the effects of dietary antioxidants on platelet-mediated thrombosis.
- To explore the potential of nutrigenomics and nutraceuticals in managing cardiovascular inflammation and thrombosis.
- To discuss therapeutic opportunities in nutrigenomics and nutraceuticals for vascular and nonvascular diseases.
Main Methods:
- Literature review on dietary antioxidants and thrombosis.
- Analysis of the role of reactive oxygen/nitrogen species in platelet activation.
- Exploration of nutrigenomics and nutraceutical approaches for cardiovascular health.
Main Results:
- Dietary antioxidants modulate platelet-mediated thrombosis.
- Nutrigenomics and nutraceuticals present a personalized, diet-based therapeutic strategy.
- This approach may overcome limitations of traditional antioxidant therapies.
Conclusions:
- Nutrigenomics and nutraceuticals hold significant potential for preventing and managing thrombosis.
- Personalized, diet-based therapeutics offer a promising avenue for cardiovascular health.
- Further mechanistic research is warranted to optimize these approaches.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...